These data suggest that the artificially increased systemic inflammation induced by LPS caused cognitive deficits and the release of pro-inflammatory mediators, while the systemic administration of nt-p65-TMD suppressed the LPS-induced cognitive dysfunction and inflammatory amplification. This evidence concerns the gene RELA and Cognitive impairment.